Friday, Jan 9, 2026 · SEC filings
What the smart money revealed on Jan 9
358 insider filings came in. We hid 78 planned (10b5-1) sellers and 220 people whose filings were routine, like grants and tax withholding.
Zenas BioPharma (ZBIO) CEO Leon Moulder bought $1.64M
100,000 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 5 checked quarters beat the typical stock 6 months later.
Navan (NAVN) Director Benjamin Horowitz bought $839K
46,337 shares on the open market. Not a grant or an option exercise.
Dorian LPG (LPG) President and CEO John Hadjipateras bought $410K
15,000 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 3 checked quarters beat the typical stock 6 months later.
TriplePoint Venture Growth BDC (TPVG) CEO James Labe bought $310K
47,710 shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 3 checked quarters beat the typical stock 6 months later.
Argan (AGX) Director Peter Getsinger sold $3.38M
Not marked as a planned 10b5-1 sale. Sold 57% of the shares they held directly. Still holds 7,847 shares.
Flex (FLEX) CFO Kevin Krumm sold $1.31M
Not marked as a planned 10b5-1 sale. Sold 13% of the shares they held directly. Still holds 143,803 shares.
Gulfport Energy (GPOR) SVP Lester Zitkus sold $881K
Not marked as a planned 10b5-1 sale. Sold 38% of the shares they held directly. Still holds 7,821 shares.
Show 11 more real buys
Show 25 more real sales
13F season
Holdings as of Dec 31, 2025 are due Feb 17
320 funds have filed so far. 81 filed for the quarter before.
Biggest real insider buys, Jan 3–9
Open-market buys by officers and directors, filed in the 7 days up to Jan 9.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.